MedGenome to present on OncoMD, a genomics data analysis and interpretation platform, for cancer discovery research at the AACR Conference 2016

OncoMD Cancer Analytics Platform combines tumor mutation profiles, expression signatures, copy number variations, epigenetic alterations and drug sensitivity to create a holistic view of human cancer enabling discovery of new targets for therapy and prognosis.